WFDC2 and ovarian carcinoma: HE4 concentrations in serum and peritoneal fluid, CA125 concentrations in serum in patients with ovarian cancer (group I) according to FIGO stage, peritoneal carcinomatosis and presence of neoplastic cells in peritoneal fluid